Pulmonary Hypertension in Interstitial Lung Disease

NCT01443598 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 224

Last updated 2016-06-08

No results posted yet for this study

Summary

HYPID study is an observational and prospective study of patients with interstitial lung disease and pre capillary hypertension diagnosed by right heart sided catheterization. The primary aim of the study is to identify prognostic factors.

Conditions

Sponsors & Collaborators

  • Hospices Civils de Lyon

    collaborator OTHER
  • Groupe d'Etudes et de Recherche sur les Maladies Orphelines Pulmonaires

    lead OTHER

Principal Investigators

  • Vincent Cottin, MD · Hospices Civils de Lyon / University Lyon I

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-07-31
Primary Completion
2011-12-31
Completion
2016-06-30

Countries

  • France

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01443598 on ClinicalTrials.gov